Moltiple sclerosis.
Conditions
Interventions
Intervention 1: Intervention group: Along with the standard treatment of MS, they will take neurocid medicine at a dose of 500 mg every 12 hours for a period of 3 months. Intervention 2: Control group
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: A patient with MS (multiple sclerosis). Age more than 20 years.
Exclusion criteria
Exclusion criteria: Patients who are very old or have very severe and old complications of MS, including severe and old muscle atrophy or ankylosis or severe joint deformity. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptom improvement percentage. Timepoint: Before the start of the intervention and three months after the start of the project. Method of measurement: Based on the observation of the specialist doctor or the patient's own statements.;Paraclinical changes. Timepoint: before the start of the intervention and 3 months after the start of the intervention. Method of measurement: Doing an MRI.;Changes in inflammatory cytokines. Timepoint: before the start of the intervention and 3 months after the start of the intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyyed Mohammad Reza Hashemizadeh
Islamic Azad University
Outcome results
None listed